Cite
HARVARD Citation
Tiede, A. et al. (2017). Pharmacokinetics of a novel extended half‐life glycoPEGylated factor IX, nonacog beta pegol (N9‐GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials. Haemophilia. 23 (4), pp. 547-555. [Online].